妇产科指南

订阅

MedSci主页 / 所有栏目 / 妇产科指南

2018 ACOG实践简报：妊娠期血栓栓塞症（No.196）

2018-07-01 美国妇产科医师学会 Obstet Gynecol. 2018 Jul;132(1):e18-e34.

妊娠期血栓栓塞症

2018年7月，美国妇产科医师学会(ACOG)发布了妊娠期血栓栓塞症管理实践建议，妊娠和产后妇女血栓栓塞风险增加了4-5倍，本文主要针对妊娠期血栓栓塞症风险筛查以及分娩前后抗凝管理提供指导建议。

中文标题：

2018 ACOG实践简报：妊娠期血栓栓塞症（No.196）

英文标题：

ACOG Practice Bulletin No. 196: Thromboembolism in Pregnancy.

发布机构：

美国妇产科医师学会

发布日期：

2018-07-01

简要介绍：

2018年7月，美国妇产科医师学会(ACOG)发布了妊娠期血栓栓塞症管理实践建议，妊娠和产后妇女血栓栓塞风险增加了4-5倍，本文主要针对妊娠期血栓栓塞症风险筛查以及分娩前后抗凝管理提供指导建议。 

拓展指南：与妊娠期相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 ACOG实践简报：妊娠期血栓栓塞症（No.196）)] GetToolGuiderByIdResponse(projectId=1, id=984501c001611230, title=2018 ACOG实践简报：妊娠期血栓栓塞症（No.196）, enTitle=ACOG Practice Bulletin No. 196: Thromboembolism in Pregnancy., guiderFrom=Obstet Gynecol. 2018 Jul;132(1):e18-e34., authorId=null, author=, summary=2018年7月，美国妇产科医师学会(ACOG)发布了妊娠期血栓栓塞症管理实践建议，妊娠和产后妇女血栓栓塞风险增加了4-5倍，本文主要针对妊娠期血栓栓塞症风险筛查以及分娩前后抗凝管理提供指导建议。 , cover=, journalId=null, articlesId=null, associationId=357, associationName=美国妇产科医师学会, associationIntro=美国妇产科医师学会(ACOG)，前身为美国妇产科学院，是一个美国妇产科妇科专业医生的专业协会。ACOG拥有超过55000名会员，其中90% 的会员是在美国经执业认证的妇产科医生。Obstetrics & Gynecology是ACOG的官方刊物。通常被称为&ldquo;绿色杂志&rdquo;。 American College of Obstetricians and Gynecologists, copyright=0, guiderPublishedTime=Sun Jul 01 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>2018年7月，美国妇产科医师学会(ACOG)发布了妊娠期血栓栓塞症管理实践建议，妊娠和产后妇女血栓栓塞风险增加了4-5倍，本文主要针对妊娠期血栓栓塞症风险筛查以及分娩前后抗凝管理提供指导建议。 </div> <div><br> </div>拓展指南：<strong>与<font color=red>妊娠期</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=636291c001608845" title="2018 ACOG实践简报：妊娠期遗传性易栓症（No.197）" target=_blank>2018 ACOG实践简报：妊娠期遗传性易栓症（No.197）</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=fef571c001600ebf" title="2018 ISSHP国际实践建议：妊娠期高血压疾病的分类，诊断和管理" target=_blank>2018 ISSHP国际实践建议：妊娠期高血压疾病的分类，诊断和管理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=7ca491c0015e59c2" title="2018 ACOG委员会意见：妊娠期间流感疫苗接种（No.732）" target=_blank>2018 ACOG委员会意见：妊娠期间流感疫苗接种（No.732）</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=c92731c0015615b2" title="2018 ACOG实践简报：妊娠期间同种异体免疫的管理（No.181）" target=_blank>2018 ACOG实践简报：妊娠期间同种异体免疫的管理（No.181）</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=769dc1c0015508d1" title="2018 ACOG实践简报：妊娠期糖尿病（No.190）-临床更新" target=_blank>2018 ACOG实践简报：妊娠期糖尿病（No.190）-临床更新</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E5%A6%8A%E5%A8%A0%E6%9C%9F" target=_blank>有关妊娠期更多指南</a></ul>, tagList=[TagDto(tagId=77246, tagName=妊娠期血栓栓塞症)], categoryList=[CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5053, appHits=216, showAppHits=0, pcHits=3726, showPcHits=1799, likes=96, shares=11, comments=14, approvalStatus=1, publishedTime=Tue Jul 03 23:26:11 CST 2018, publishedTimeString=2018-07-01, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue Jul 03 23:26:11 CST 2018, updatedBy=null, updatedName=null, updatedTime=Thu Jan 04 06:53:55 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 ACOG实践简报：妊娠期血栓栓塞症（No.196）)])
2018 ACOG实践简报：妊娠期血栓栓塞症（No.196）
下载请点击：
评论区 (13)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1005668, encodeId=0509100566878, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210806/9d03995b3ef94e86ac6046707cb716e8/17ecb63c30d44a80b845aff1e230dd4f.jpg, createdBy=f1ca5227485, createdName=1977刘刘, createdTime=Fri Aug 06 19:42:47 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005667, encodeId=7727100566ef5, content=太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210806/9d03995b3ef94e86ac6046707cb716e8/17ecb63c30d44a80b845aff1e230dd4f.jpg, createdBy=f1ca5227485, createdName=1977刘刘, createdTime=Fri Aug 06 19:42:08 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005655, encodeId=e97410056557a, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210806/9d03995b3ef94e86ac6046707cb716e8/17ecb63c30d44a80b845aff1e230dd4f.jpg, createdBy=f1ca5227485, createdName=1977刘刘, createdTime=Fri Aug 06 18:31:22 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960934, encodeId=cc819609340f, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210427/493f0df1d64843c08a6b82df2ec3a16e/9b4a8ab3a3304eac957cba27a4779183.jpeg, createdBy=76aa3806739, createdName=Mario, createdTime=Tue Apr 27 13:57:46 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954811, encodeId=c3bc95481131, content=已看，还可以。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 15:25:03 CST 2021, time=2021-04-07, status=1, ipAttribution=)]
    2021-08-06 1977刘刘

    感谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1005668, encodeId=0509100566878, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210806/9d03995b3ef94e86ac6046707cb716e8/17ecb63c30d44a80b845aff1e230dd4f.jpg, createdBy=f1ca5227485, createdName=1977刘刘, createdTime=Fri Aug 06 19:42:47 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005667, encodeId=7727100566ef5, content=太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210806/9d03995b3ef94e86ac6046707cb716e8/17ecb63c30d44a80b845aff1e230dd4f.jpg, createdBy=f1ca5227485, createdName=1977刘刘, createdTime=Fri Aug 06 19:42:08 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005655, encodeId=e97410056557a, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210806/9d03995b3ef94e86ac6046707cb716e8/17ecb63c30d44a80b845aff1e230dd4f.jpg, createdBy=f1ca5227485, createdName=1977刘刘, createdTime=Fri Aug 06 18:31:22 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960934, encodeId=cc819609340f, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210427/493f0df1d64843c08a6b82df2ec3a16e/9b4a8ab3a3304eac957cba27a4779183.jpeg, createdBy=76aa3806739, createdName=Mario, createdTime=Tue Apr 27 13:57:46 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954811, encodeId=c3bc95481131, content=已看，还可以。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 15:25:03 CST 2021, time=2021-04-07, status=1, ipAttribution=)]
    2021-08-06 1977刘刘

    太好了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1005668, encodeId=0509100566878, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210806/9d03995b3ef94e86ac6046707cb716e8/17ecb63c30d44a80b845aff1e230dd4f.jpg, createdBy=f1ca5227485, createdName=1977刘刘, createdTime=Fri Aug 06 19:42:47 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005667, encodeId=7727100566ef5, content=太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210806/9d03995b3ef94e86ac6046707cb716e8/17ecb63c30d44a80b845aff1e230dd4f.jpg, createdBy=f1ca5227485, createdName=1977刘刘, createdTime=Fri Aug 06 19:42:08 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005655, encodeId=e97410056557a, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210806/9d03995b3ef94e86ac6046707cb716e8/17ecb63c30d44a80b845aff1e230dd4f.jpg, createdBy=f1ca5227485, createdName=1977刘刘, createdTime=Fri Aug 06 18:31:22 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960934, encodeId=cc819609340f, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210427/493f0df1d64843c08a6b82df2ec3a16e/9b4a8ab3a3304eac957cba27a4779183.jpeg, createdBy=76aa3806739, createdName=Mario, createdTime=Tue Apr 27 13:57:46 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954811, encodeId=c3bc95481131, content=已看，还可以。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 15:25:03 CST 2021, time=2021-04-07, status=1, ipAttribution=)]
    2021-08-06 1977刘刘

    感谢

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1005668, encodeId=0509100566878, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210806/9d03995b3ef94e86ac6046707cb716e8/17ecb63c30d44a80b845aff1e230dd4f.jpg, createdBy=f1ca5227485, createdName=1977刘刘, createdTime=Fri Aug 06 19:42:47 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005667, encodeId=7727100566ef5, content=太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210806/9d03995b3ef94e86ac6046707cb716e8/17ecb63c30d44a80b845aff1e230dd4f.jpg, createdBy=f1ca5227485, createdName=1977刘刘, createdTime=Fri Aug 06 19:42:08 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005655, encodeId=e97410056557a, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210806/9d03995b3ef94e86ac6046707cb716e8/17ecb63c30d44a80b845aff1e230dd4f.jpg, createdBy=f1ca5227485, createdName=1977刘刘, createdTime=Fri Aug 06 18:31:22 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960934, encodeId=cc819609340f, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210427/493f0df1d64843c08a6b82df2ec3a16e/9b4a8ab3a3304eac957cba27a4779183.jpeg, createdBy=76aa3806739, createdName=Mario, createdTime=Tue Apr 27 13:57:46 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954811, encodeId=c3bc95481131, content=已看，还可以。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 15:25:03 CST 2021, time=2021-04-07, status=1, ipAttribution=)]
    2021-04-27 Mario

    感谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1005668, encodeId=0509100566878, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210806/9d03995b3ef94e86ac6046707cb716e8/17ecb63c30d44a80b845aff1e230dd4f.jpg, createdBy=f1ca5227485, createdName=1977刘刘, createdTime=Fri Aug 06 19:42:47 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005667, encodeId=7727100566ef5, content=太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210806/9d03995b3ef94e86ac6046707cb716e8/17ecb63c30d44a80b845aff1e230dd4f.jpg, createdBy=f1ca5227485, createdName=1977刘刘, createdTime=Fri Aug 06 19:42:08 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005655, encodeId=e97410056557a, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210806/9d03995b3ef94e86ac6046707cb716e8/17ecb63c30d44a80b845aff1e230dd4f.jpg, createdBy=f1ca5227485, createdName=1977刘刘, createdTime=Fri Aug 06 18:31:22 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960934, encodeId=cc819609340f, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210427/493f0df1d64843c08a6b82df2ec3a16e/9b4a8ab3a3304eac957cba27a4779183.jpeg, createdBy=76aa3806739, createdName=Mario, createdTime=Tue Apr 27 13:57:46 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954811, encodeId=c3bc95481131, content=已看，还可以。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 15:25:03 CST 2021, time=2021-04-07, status=1, ipAttribution=)]
    2021-04-07 ms6000001015893838

    已看，还可以。

    0

以上为热门评论，梅斯医学App还有更多内容